BC2L-C N-Terminal Lectin Domain Complexed with Histo Blood Group Oligosaccharides Provides New Structural Information
Overview
Affiliations
Lectins mediate adhesion of pathogens to host tissues, filling in a key role in the first steps of infection. Belonging to the opportunistic pathogen , BC2L-C is a superlectin with dual carbohydrate specificity, believed to mediate cross-linking between bacteria and host cells. Its C-terminal domain binds to bacterial mannosides while its N-terminal domain (BCL2-CN) recognizes fucosylated human epitopes. BC2L-CN presents a tumor necrosis factor alpha (TNF-) fold previously unseen in lectins with a novel fucose binding mode. We report, here, the production of a novel recombinant form of BC2L-CN (rBC2L-CN2), which allowed better protein stability and unprecedented co-crystallization with oligosaccharides. Isothermal calorimetry measurements showed no detrimental effect on ligand binding and data were obtained on the binding of Globo H hexasaccharide and l-galactose. Crystal structures of rBC2L-CN2 were solved in complex with two blood group antigens: H-type 1 and H-type 3 (Globo H) by X-ray crystallography. They provide new structural information on the binding site, of importance for the structural-based design of glycodrugs as new antimicrobials with antiadhesive properties.
Tandem-repeat lectins: structural and functional insights.
Olvera-Lucio F, Riveros-Rosas H, Quintero-Martinez A, Hernandez-Santoyo A Glycobiology. 2024; 34(7).
PMID: 38857376 PMC: 11186620. DOI: 10.1093/glycob/cwae041.
Glycomimetic antagonists of BC2L-C lectin: insights from molecular dynamics simulations.
Antonini G, Civera M, Lal K, Mazzotta S, Varrot A, Bernardi A Front Mol Biosci. 2023; 10:1201630.
PMID: 37325481 PMC: 10264699. DOI: 10.3389/fmolb.2023.1201630.
Mazzotta S, Antonini G, Vasile F, Gillon E, Lundstrom J, Varrot A Molecules. 2023; 28(3).
PMID: 36771163 PMC: 9919437. DOI: 10.3390/molecules28031494.
Targeting a Multidrug-Resistant Pathogen: First Generation Antagonists of 's BC2L-C Lectin.
Bermeo R, Lal K, Ruggeri D, Lanaro D, Mazzotta S, Vasile F ACS Chem Biol. 2022; 17(10):2899-2910.
PMID: 36174276 PMC: 9594048. DOI: 10.1021/acschembio.2c00532.
Bleuler-Martinez S, Varrot A, Olieric V, Schubert M, Vogt E, Fetz C Glycobiology. 2022; 32(7):600-615.
PMID: 35323921 PMC: 9191617. DOI: 10.1093/glycob/cwac020.